November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
North America dominated the human blood products market, fueled by regular donation drives, widespread facilities and government efforts to improve blood storage and awareness. In the U.S., 6.8 million people donate annually, while 52% of Canadians have needed blood or blood products....
November 01, 2025
In 2023, children led the global bone-anchored hearing aids (BAHA) implants market due to higher rates of hearing loss compared to adults. While children under 5 often need BAHA implants, the adult market, especially among the elderly, is set for growth. BAHA is widely used for sensorineural hearing loss....
November 01, 2025
Based on market forecasts, the nebulizer devices sector will expand from USD 1.23 billion in 2024 to USD 2.2 billion by 2034, experiencing a CAGR of 5.94%. The rising incidences of chronic respiratory disorders, advancements in medical devices, and increasing investments drive the market....
November 01, 2025
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific shows strong growth potential. Key players include Novartis, Sobi, and Shionogi....
November 01, 2025
The in-ear hearing aids market was dominated by the ITE-half shell segment, known for its comfort and effectiveness in treating mild-to-moderate hearing loss. The ITE-full shell segment is expected to grow significantly, offering more amplification for moderate-to-severe cases. Additionally, age-related hearing loss is the leading application, driv...
November 01, 2025
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023, the U.S. FDA authorized Teva's Alvaiz (eltrombopag) tablets for treating thrombocytopenia in adults...
November 01, 2025
Polymerase chain reaction (PCR) is a DNA amplification method widely used in diagnostics and biotechnology. In 2022, India conducted 600-700 million diagnostic tests, adding 1,390 biotech startups. PCR enzymes drive efficiency and sustainability. The U.S. and UK continue to invest heavily in biotech innovation....
November 01, 2025
The nerve repair and regeneration market grows with rising nerve injuries from accidents, chronic disorders, and trauma. Companies like Progentos and Neuraptive advance treatments, with Axogen reporting growth in surgical solutions for peripheral nerve repair. Innovation drives this expanding field....
November 01, 2025
The global human coagulation factor VII market is projected to grow from USD 1.21 billion in 2023 to USD 1.82 billion by 2034, driven by rising surgeries, trauma cases, and hemophilia prevalence. North America leads, while Asia Pacific is the fastest-growing region....
November 01, 2025
The Hepatitis A vaccine market, valued at US$ 759.01 million in 2024, is projected to reach US$ 948.16 million by 2034. Growth is driven by rising outbreaks, immunization awareness, and travel. Asia-Pacific leads, with North America growing fastest; key players include GSK, Merck, and Sanofi....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com